2023
DOI: 10.1016/j.bbi.2023.07.021
|View full text |Cite
|
Sign up to set email alerts
|

Advancing the preclinical study of comorbid neuroHIV and substance use disorders: Current perspectives and future directions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
4
0

Year Published

2024
2024
2025
2025

Publication Types

Select...
4
2
1

Relationship

1
6

Authors

Journals

citations
Cited by 10 publications
(8 citation statements)
references
References 323 publications
0
4
0
Order By: Relevance
“…One notable difference includes the absence of gp120, which is a known mediator of deleterious immune and neural outcomes in HIV-1 infection (Gemma et al, 2000;Hill et al, 2019). While consistent with general peripheral and CNS immune system dysregulation observed in rodent models of HIV (Fitting et al, 2013;Melendez et al, 2016;Namba et al, 2023a), the time course of EcoHIV infection differs from HIV-1 (Gu et al, 2018). In the current study, we report that EcoHIV-infected mice showed viral DNA burdens of up to 0.3-5 x 10 3 viral DNA copies per 10 6 spleen cells with 5 weeks of infection.…”
Section: Discussionmentioning
confidence: 87%
See 1 more Smart Citation
“…One notable difference includes the absence of gp120, which is a known mediator of deleterious immune and neural outcomes in HIV-1 infection (Gemma et al, 2000;Hill et al, 2019). While consistent with general peripheral and CNS immune system dysregulation observed in rodent models of HIV (Fitting et al, 2013;Melendez et al, 2016;Namba et al, 2023a), the time course of EcoHIV infection differs from HIV-1 (Gu et al, 2018). In the current study, we report that EcoHIV-infected mice showed viral DNA burdens of up to 0.3-5 x 10 3 viral DNA copies per 10 6 spleen cells with 5 weeks of infection.…”
Section: Discussionmentioning
confidence: 87%
“…Together, these findings point to a need to understand the independent and interactive effects of HIV infection and ART on peripheral and CNS immune outcomes, necessitating preclinical models of HIV (Buch et al, 2011; Gorantla et al, 2012; Edagwa et al, 2014; Namba et al, 2023a). To accomplish this, the current study utilized the EcoHIV infection mouse model, in which a chimeric virus is generated by replacing the coding region of the HIV-1 glycoprotein gp120 with that of gp80 (Potash et al, 2005).…”
Section: Introductionmentioning
confidence: 99%
“…By employing computational and mathematical techniques, scientists can predict a protein’s structure, stability, and activity. This information can lead to the identification of novel drug targets for diseases such as cancer, HIV, and Alzheimer’s , and improve the development of new drug therapies. , Accurate and efficient protein function prediction methods are urgently needed, and further research is required to develop and apply these methods to a broader range of biological processes.…”
Section: Introductionmentioning
confidence: 99%
“…Infectious diseases, including Acquired Immune Deficiency Syndrome, tuberculosis, and COVID-19, contribute to substance abuse and addictive disorders [ [1] , [2] , [3] ]. Lyme disease/Lyme borreliosis (LD) and addictive disorders have been reviewed [ 4 ], and studies show an association between LD and substance abuse [ [5] , [6] , [7] , [8] ], with some people becoming dependent upon psychoactive substances [ 6 ].…”
Section: Introductionmentioning
confidence: 99%